- Home
- SEER vs ZTEK Comparison
SEER vs ZTEK Comparison
Compare SEER & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEER | ZTEK |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.0M | 89.3M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SEER | ZTEK |
|---|---|---|
| Price | $1.90 | $0.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 154.7K | 43.4K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,376,999.00 | $657,134.00 |
| Revenue This Year | $25.97 | N/A |
| Revenue Next Year | $24.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 12.11 | ★ 2225.73 |
| 52 Week Low | $1.62 | $0.62 |
| 52 Week High | $2.59 | $1.84 |
Technical Indicators
Market Signals| Indicator | SEER | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 35.38 | 45.58 |
| Support Level | $1.91 | $0.70 |
| Resistance Level | $2.02 | $0.79 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 31.83 | 43.84 |
Price Performance
Historical ComparisonAbout SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.